[HTML][HTML] Radiotherapy combined with immunotherapy: the dawn of cancer treatment
Z Zhang, X Liu, D Chen, J Yu - Signal transduction and targeted …, 2022 - nature.com
Radiotherapy (RT) is delivered for purposes of local control, but can also exert systemic
effect on remote and non-irradiated tumor deposits, which is called abscopal effect. The view …
effect on remote and non-irradiated tumor deposits, which is called abscopal effect. The view …
[HTML][HTML] Radon and lung cancer: current trends and future perspectives
M Riudavets, M Garcia de Herreros, B Besse… - Cancers, 2022 - mdpi.com
Simple Summary Radon represents the main risk factor of lung cancer in non-smokers and
the second one in smoking patients. In Europe, there are several radon-prone areas, but …
the second one in smoking patients. In Europe, there are several radon-prone areas, but …
Expert consultation is vital for adverse outcome pathway development: a case example of cardiovascular effects of ionizing radiation
V Chauhan, N Hamada, V Monceau… - … Journal of Radiation …, 2021 - Taylor & Francis
Background The circulatory system distributes nutrients, signaling molecules, and immune
cells to vital organs and soft tissues. Epidemiological, animal, and in vitro cellular …
cells to vital organs and soft tissues. Epidemiological, animal, and in vitro cellular …
[HTML][HTML] Microbeam radiotherapy—a novel therapeutic approach to overcome radioresistance and enhance anti-tumour response in melanoma
V Trappetti, JM Fazzari, C Fernandez-Palomo… - International journal of …, 2021 - mdpi.com
Melanoma is the deadliest type of skin cancer, due to its invasiveness and limited treatment
efficacy. The main therapy for primary melanoma and solitary organ metastases is wide …
efficacy. The main therapy for primary melanoma and solitary organ metastases is wide …
[HTML][HTML] Imaging drug delivery to the lungs: Methods and applications in oncology
Direct delivery to the lung via inhalation is arguably one of the most logical approaches to
treat lung cancer using drugs. However, despite significant efforts and investment in this …
treat lung cancer using drugs. However, despite significant efforts and investment in this …
[HTML][HTML] Low-Dose Non-Targeted Effects and Mitochondrial Control
D Averbeck - International Journal of Molecular Sciences, 2023 - mdpi.com
Non-targeted effects (NTE) have been generally regarded as a low-dose ionizing radiation
(IR) phenomenon. Recently, regarding long distant abscopal effects have also been …
(IR) phenomenon. Recently, regarding long distant abscopal effects have also been …
[HTML][HTML] Therapeutic potential of low dose ionizing radiation against cancer, dementia, and diabetes: evidences from epidemiological, clinical, and preclinical studies
The growing use of ionizing radiation (IR)-based diagnostic and treatment methods has
been linked to increasing chronic diseases among patients and healthcare professionals …
been linked to increasing chronic diseases among patients and healthcare professionals …
[HTML][HTML] Renal Disturbances during and after Radioligand Therapy of Neuroendocrine Tumors—Extended Analysis of Potential Acute and Chronic Complications
M Saracyn, AD Durma, B Bober, A Lubas… - International Journal of …, 2023 - mdpi.com
Neuroendocrine tumors (NEN) are a group of neoplasms that arise from hormonal and
neural cells. Despite a common origin, their clinical symptoms and outcomes are varied …
neural cells. Despite a common origin, their clinical symptoms and outcomes are varied …
Mechanism and protection of radiotherapy induced sensorineural hearing loss for head and neck cancer
W Shi, X Hou, X Bao, W Hou, X Jiang… - BioMed Research …, 2021 - Wiley Online Library
Purpose. Radiotherapy‐induced sensorineural hearing loss (RISNHL) is a common adverse
effect in patients with head and neck cancer. Given that there are few studies on the …
effect in patients with head and neck cancer. Given that there are few studies on the …
Exploring low-dose radiotherapy to overcome radio-immunotherapy resistance
J Wang, J Zhang, W Wen, F Wang, M Wu… - … et Biophysica Acta (BBA …, 2023 - Elsevier
Immune checkpoint inhibitors (ICIs) have revolutionized the current treatment landscape for
cancer, yet the response rates of ICIs remain unmet. Synergistic with immunotherapy, low …
cancer, yet the response rates of ICIs remain unmet. Synergistic with immunotherapy, low …